Population based study of psychotropic medication use during pregnancy

Project number: 
02-017
Approval date: 
Wednesday, August 21, 2002
Principal Investigator: 
Oberlander,Tim
Institution: 
Not Available
Funding Agency: 
Not Available
Datasets requested: 
Not available
Research objective: 
Publications: 

Journal Publication

  • Oberlander, T. F.; Warburton, W.; Misri, S.; Aghajanian, J.; Hertzman, C. "Effects of timing and duration of gestational exposure to serotonin reuptake inhibitor antidepressants: population-based study." The British Journal of Psychiatry : the Journal of Mental Science (2008) 192 5 338-343
  • Oberlander, T. F.; Warburton, W.; Misri, S.; Riggs, W.; Aghajanian, J.; Hertzman, C. "Major congenital malformations following prenatal exposure to serotonin reuptake inhibitors and benzodiazepines using population-based health data." Birth defects research.Part B, Developmental and reproductive toxicology (2008) 83 1 68-76
  • Oberlander, T. F.; Warburton, W.; Misri, S.; Aghajanian, J.; Hertzman, C. "Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data." Archives of General Psychiatry (2006) 63 8 898-906
  • Oberlander, T. F.; Warburton, W.; Misri,S.; Aghajanian, J.; Hertzman, C. "Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data." Archives of General Psychiatry (2006) 63 8 898-906

Page last revised: December 5, 2017